Estimating The Intrinsic Value Of Imperva Inc (NASDAQ:IMPV)

I am going to run you through how I calculated the intrinsic value of Imperva Inc (NASDAQ:IMPV) by taking the foreast future cash flows of the company and discounting them back to today’s value. I will be using the Discounted Cash Flows (DCF) model. Don’t get put off by the jargon, the math behind it is actually quite straightforward. Anyone interested in learning a bit more about intrinsic value should have a read of the Simply Wall St analysis model. If you are reading this and its not July 2018 then I highly recommend you check out the latest calculation for Imperva by following the link below.

View our latest analysis for Imperva

The calculation

I’m using the 2-stage growth model, which simply means we take in account two stages of company’s growth. In the initial period the company may have a higher growth rate and the second stage is usually assumed to have perpetual stable growth rate. To begin with we have to get estimates of the next five years of cash flows. Where possible I use analyst estimates, but when these aren’t available I have extrapolated the previous free cash flow (FCF) from the year before. For this growth rate I used the average annual growth rate over the past five years, but capped at a reasonable level. The sum of these cash flows is then discounted to today’s value.

5-year cash flow estimate

2018 2019 2020 2021 2022
Levered FCF ($, Millions) $73.65 $95.12 $124.90 $146.13 $169.51
Source Analyst x10 Analyst x10 Analyst x1 Extrapolated @ (17%, capped from 21.48%) Extrapolated @ (16%, capped from 21.48%)
Present Value Discounted @ 9.71% $67.14 $79.04 $94.59 $100.88 $106.67

Present Value of 5-year Cash Flow (PVCF)= US$448.31m

The second stage is also known as Terminal Value, this is the business’s cash flow after the first stage. The Gordon Growth formula is used to calculate Terminal Value at an annual growth rate equal to the 10-year government bond rate of 2.9%. We discount this to today’s value at a cost of equity of 9.7%.

Terminal Value (TV) = FCF2022 × (1 + g) ÷ (r – g) = US$169.51m × (1 + 2.9%) ÷ (9.7% – 2.9%) = US$2.58b

Present Value of Terminal Value (PVTV) = TV / (1 + r)5 = US$2.58b ÷ ( 1 + 9.7%)5 = US$1.63b

The total value is the sum of cash flows for the next five years and the discounted terminal value, which results in the Total Equity Value, which in this case is US$2.07b. The last step is to then divide the equity value by the number of shares outstanding. If the stock is an depositary receipt (represents a specified number of shares in a foreign corporation) then we use the equivalent number. This results in an intrinsic value of $59.76. Compared to the current share price of $56.6, the stock is about right, perhaps slightly undervalued at a 5.29% discount to what it is available for right now.

NasdaqGS:IMPV Intrinsic Value Export July 27th 18
NasdaqGS:IMPV Intrinsic Value Export July 27th 18

The assumptions

Now the most important inputs to a discounted cash flow are the discount rate, and of course, the actual cash flows. You don’t have to agree with my inputs, I recommend redoing the calculations yourself and playing with them. Because we are looking at Imperva as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighed average cost of capital, WACC) which accounts for debt. In this calculation I’ve used 9.7%, which is based on a levered beta of 0.958. This is derived from the Bottom-Up Beta method based on comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.

Next Steps:

Valuation is only one side of the coin in terms of building your investment thesis, and it shouldn’t be the only metric you look at when researching a company. For IMPV, I’ve compiled three relevant factors you should look at:

  1. Financial Health: Does IMPV have a healthy balance sheet? Take a look at our free balance sheet analysis with six simple checks on key factors like leverage and risk.
  2. Future Earnings: How does IMPV’s growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.
  3. Other High Quality Alternatives: Are there other high quality stocks you could be holding instead of IMPV? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing!

PS. Simply Wall St does a DCF calculation for every US stock every 6 hours, so if you want to find the intrinsic value of any other stock just search here.

To help readers see past the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price-sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned. For errors that warrant correction please contact the editor at editorial-team@simplywallst.com.